Cargando…

A Fixed-Dose Combination of Ofloxacin-Ornidazole Induced Fixed Drug Eruption: A Case Report

Cutaneous drug eruptions are commonly occurring adverse drug reactions. Food and Drug Association does not recommend a fixed dose combination of ofloxacin-ornidazole; still, it is commonly practised in developing countries. Many patients take this combination of drugs for episodes of gastro-enteriti...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarkar, Manuj K, Dey, Subhra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064256/
https://www.ncbi.nlm.nih.gov/pubmed/37009390
http://dx.doi.org/10.7759/cureus.35630
_version_ 1785017864555593728
author Sarkar, Manuj K
Dey, Subhra
author_facet Sarkar, Manuj K
Dey, Subhra
author_sort Sarkar, Manuj K
collection PubMed
description Cutaneous drug eruptions are commonly occurring adverse drug reactions. Food and Drug Association does not recommend a fixed dose combination of ofloxacin-ornidazole; still, it is commonly practised in developing countries. Many patients take this combination of drugs for episodes of gastro-enteritis, often as self-medication. We are reporting a 25 years old male patient presenting with repeated episodes of adverse drug reaction to a fixed dose combination of ofloxacin-ornidazole.
format Online
Article
Text
id pubmed-10064256
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-100642562023-04-01 A Fixed-Dose Combination of Ofloxacin-Ornidazole Induced Fixed Drug Eruption: A Case Report Sarkar, Manuj K Dey, Subhra Cureus Dermatology Cutaneous drug eruptions are commonly occurring adverse drug reactions. Food and Drug Association does not recommend a fixed dose combination of ofloxacin-ornidazole; still, it is commonly practised in developing countries. Many patients take this combination of drugs for episodes of gastro-enteritis, often as self-medication. We are reporting a 25 years old male patient presenting with repeated episodes of adverse drug reaction to a fixed dose combination of ofloxacin-ornidazole. Cureus 2023-03-01 /pmc/articles/PMC10064256/ /pubmed/37009390 http://dx.doi.org/10.7759/cureus.35630 Text en Copyright © 2023, Sarkar et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Sarkar, Manuj K
Dey, Subhra
A Fixed-Dose Combination of Ofloxacin-Ornidazole Induced Fixed Drug Eruption: A Case Report
title A Fixed-Dose Combination of Ofloxacin-Ornidazole Induced Fixed Drug Eruption: A Case Report
title_full A Fixed-Dose Combination of Ofloxacin-Ornidazole Induced Fixed Drug Eruption: A Case Report
title_fullStr A Fixed-Dose Combination of Ofloxacin-Ornidazole Induced Fixed Drug Eruption: A Case Report
title_full_unstemmed A Fixed-Dose Combination of Ofloxacin-Ornidazole Induced Fixed Drug Eruption: A Case Report
title_short A Fixed-Dose Combination of Ofloxacin-Ornidazole Induced Fixed Drug Eruption: A Case Report
title_sort fixed-dose combination of ofloxacin-ornidazole induced fixed drug eruption: a case report
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064256/
https://www.ncbi.nlm.nih.gov/pubmed/37009390
http://dx.doi.org/10.7759/cureus.35630
work_keys_str_mv AT sarkarmanujk afixeddosecombinationofofloxacinornidazoleinducedfixeddrugeruptionacasereport
AT deysubhra afixeddosecombinationofofloxacinornidazoleinducedfixeddrugeruptionacasereport
AT sarkarmanujk fixeddosecombinationofofloxacinornidazoleinducedfixeddrugeruptionacasereport
AT deysubhra fixeddosecombinationofofloxacinornidazoleinducedfixeddrugeruptionacasereport